-transparent.png){kind=logo}
Ring unsubstituted dichloro(diphenylethylenediamine)platinum(II) complexes show a dependence of their antitumor activity on the configuration and position of phenyl rings in ethylenediamine ligand. Dichloro(1,1-diphenylethylenediamine)platinum(II) (1d) and meso-dichloro(1,2-diphenylethylenediamine)-platinum(II) (meso-2d) have a weaker effect on the human breast-cancer cell line MDA-MB 231 and on rat leukemia L 5222 than (+/-)-dichloro(1,2-diphenylethylenediamine)platinum(II)((+)-2d) and its enantiomers (+)-2d and (-)-2d which cause marked and comparable inhibition of both tumors; (+/-)-2d is also active on ADJ/PC 6 plasmacytoma of the mouse and on cisplatin-, daunomycin-, and cisplatin/daunomycin-resistant Ehrlich ascites tumors of the mouse. The differences in activity of the diastereomers (+/-)-2d and meso-2d, for which distinct influences on the DNA secondary structure can be demonstrated CD spectroscopically may be explained by a steric hindrance of the drug-DNA interaction.
B Wappes, and
M Jennerwein, and
E von Angerer, and
J Engel, and
H Schönenberger, and
H Brunner, and
M Schmidt, and
M Berger, and
D Schmähl, and
S Seeber
January 1989,
The Prostate,
B Wappes, and
M Jennerwein, and
E von Angerer, and
J Engel, and
H Schönenberger, and
H Brunner, and
M Schmidt, and
M Berger, and
D Schmähl, and
S Seeber
May 1990,
Archiv der Pharmazie,
B Wappes, and
M Jennerwein, and
E von Angerer, and
J Engel, and
H Schönenberger, and
H Brunner, and
M Schmidt, and
M Berger, and
D Schmähl, and
S Seeber
July 2004,
Acta crystallographica. Section C, Crystal structure communications,
B Wappes, and
M Jennerwein, and
E von Angerer, and
J Engel, and
H Schönenberger, and
H Brunner, and
M Schmidt, and
M Berger, and
D Schmähl, and
S Seeber
January 1993,
Journal of cancer research and clinical oncology,
B Wappes, and
M Jennerwein, and
E von Angerer, and
J Engel, and
H Schönenberger, and
H Brunner, and
M Schmidt, and
M Berger, and
D Schmähl, and
S Seeber
December 2008,
Cancer chemotherapy and pharmacology,
B Wappes, and
M Jennerwein, and
E von Angerer, and
J Engel, and
H Schönenberger, and
H Brunner, and
M Schmidt, and
M Berger, and
D Schmähl, and
S Seeber
May 1996,
The Journal of steroid biochemistry and molecular biology,
B Wappes, and
M Jennerwein, and
E von Angerer, and
J Engel, and
H Schönenberger, and
H Brunner, and
M Schmidt, and
M Berger, and
D Schmähl, and
S Seeber
March 2003,
Journal of medicinal chemistry,
B Wappes, and
M Jennerwein, and
E von Angerer, and
J Engel, and
H Schönenberger, and
H Brunner, and
M Schmidt, and
M Berger, and
D Schmähl, and
S Seeber
September 1984,
Chemico-biological interactions,
B Wappes, and
M Jennerwein, and
E von Angerer, and
J Engel, and
H Schönenberger, and
H Brunner, and
M Schmidt, and
M Berger, and
D Schmähl, and
S Seeber
November 1981,
Archiv der Pharmazie,
B Wappes, and
M Jennerwein, and
E von Angerer, and
J Engel, and
H Schönenberger, and
H Brunner, and
M Schmidt, and
M Berger, and
D Schmähl, and
S Seeber
February 1992,
Archiv der Pharmazie,
